Insights
Insights From Our Experts
Articles
Uncovering Health Disparities: Exploring Social Determinants of Metastatic Prostate Cancer Survival
Author(s): Imtiaz A. Samjoo, MSc, PhD; Emily Rosta, MSc; Austin Lansing, MSc; Alexandra Hall, MPH Despite recent advancements in metastatic prostate cancer (mPC) treatment, prevention and care, progress has not equally manifested in all population groups.…
EVERSANA’s High-Quality HEOR Methods Recognized in Published Independent Review
A recent independent review conducted by Serret-Larmande and colleagues, featured in the Journal of Clinical Epidemiology, meticulously evaluated population-adjusted indirect comparisons published from 2010-2022. The analysis focused on assessing the reporting quality of methods and results…
Embarking on the Care Journey: Strategies for Engaging Patients Pre- and Post-Diagnosis
Navigating the healthcare system is a complex task for any patient, but it can be particularly tricky for those who are searching for more information on their symptoms, grappling with a recent diagnosis or looking for…
HemGenix Shines in Collaborative ITC Analysis: EVERSANA and CSL Behring Propel Gene Therapy to the Forefront in Hemophilia B Treatment
CSL Behring’s gene therapy for hemophilia B, HemGenix, was evaluated in the HOPE-B Phase III trial versus a basket of conventional FIX replacement products where it was found that the gene therapy reduced the annual bleed…
Impact of the European Union Medical Device Regulation Extension on Legacy Devices
Question: The European Union (EU) has extended the transition period for medical devices under the Medical Device Regulation (MDR) and removed the sell-off provisions for existing products. How do these changes impact you? Answer: On 7…
An Impactful Year for Global Regulation of Digital Health
2023 was a busy year with FDA and EU advancing key initiatives focused on AI/ML, cybersecurity, global harmonization, real-world evidence, and pharma companion apps…and more is coming in 2024. While 2023 brought its share of challenges…
Transforming Pharmaceutical Commercialization: Eight Key Insights for Success
Unlock the keys to successful pharmaceutical commercialization with our latest article: “Transforming Pharmaceutical Commercialization: Eight Key Insights for Success.” This insightful piece explores crucial, actionable strategies to transform your approach to drug launch. Here’s a glimpse…
Commercializing Digital Health as Durable Medical Equipment: A Conversation with BearingOn.Health
Posted by
Brian Abraham on December 14, 202312/14/23
Join EVERSANA’s Brian Abraham, Senior Director of Market Access and Patient Access, as he engages in a thought-provoking conversation with Adam Kaufman of BearingOn.Health. Together, they unravel the complexities surrounding digital health commercialization and reimbursement models,…
Seven Key Takeaways From a Week at AWS re:Invent 2023
AWS re:Invent 2023 was a week full of exciting announcements, inspiring keynotes, and insightful sessions impacting all industries, including healthcare and life sciences (HCLS). The event showcases the latest and greatest innovations and developments in cloud…
Linking Channel Distribution & 3PL to Non-Traditional Commercialization Touchpoints
To be competitive, maximize products and deliver exceptional customer service, trade and channel strategies must go beyond logistics. This presentation outlines how manufacturers need to connect the dots between customer type, whether they are specialty distributors,…